Custom Search
FDA Information
In 2004, the U.S. Food and Drug Administration (FDA) approved Cardizem LA® (ditiazem) for the treatment of chronic stable angina.
Cardizem LA® had also been earlier approved for the treatment of high blood pressure or hypertension and is a long acting extended-release formulation of diltiazem HCl.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?